Alloreactive natural killer (NK) cells for allogeneic stem cell transplantation

alloreactive natural killer cells · The University of Texas MD Anderson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alloreactive natural killer (NK) cells for allogeneic stem cell transplantation, covering 2015-05-08 to 2015-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Phase 1]

See pricing